- ¥39bn
- ¥55bn
- ¥46bn
- 43
- 40
- 41
- 33
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 15.15 | ||
| PEG Ratio (f) | 0.98 | ||
| EPS Growth (f) | 18.35% | ||
| Dividend Yield (f) | 0.79% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.95 | ||
| Price to Tang. Book | 2.15 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.86 | ||
| EV to EBITDA | 13.26 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 15.03% | ||
| Return on Equity | 10.88% | ||
| Operating Margin | 6.8% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 28,763.1 | 37,393.8 | 41,205 | 42,891 | 45,628 | 50,000 | 56,000 | 12.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +6.6 | +104.91 | -1.94 | -11.78 | -21.76 | +16.79 | +21.4 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
C.I.MEDICAL CO.,LTD. is a Japan-based company engaged in mail order sales to dental clinics, dental laboratories and other various medical institutions. Mail order sales segment sells products purchased from domestic and overseas wholesalers and manufacturers to domestic dental clinic and other healthcare professionals. Mail order distributions include Ci Medical for dental clinic, nurse+care for clinic, DENTAL LABO for dental laboratory, Vet for veterinary medical materials and pharmaceutical, FreshCare for nursing care facilities and welfare facilities, Medical catalog for hospitals and general clinics, Demiline dental clinic catalog for dental clinics, dental fit for patients and the MEX business for pharmacies. It also provides computer aided design (VAD) and computer aided manufacturing (CAM) dental technology production business, dental magazine publishing business, solar power generation business, and website creation agency business for dental clinics and dental laboratories.
Directors
- Kiyoto Shimizu PRE (57)
- Yoshimitsu Kobayashi SMD (45)
- Hideaki Yutani SMD (53)
- Masaharu Yamauchi MDR (57)
- Takahiro Yamaguchi DSL
- Keiichiro Hayashi EXO
- Naonori Kawabata EXO
- Tomoko Shimizu EXO
- Seiji Miyoshi OTH (51)
- Yasuyuki Nakanishi OTH (36)
- Akira Okusawa IND (63)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 5th, 2000
- Public Since
- June 17th, 2016
- No. of Shareholders
- 1,747
- No. of Employees
- 473
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange- Shares in Issue
- 9,999,835
- Address
- 152, Ni, Fukushima-machi, NOMI-SHI, 929-0112
- Web
- https://ci-medical.co.jp/
- Phone
- +81 762788802
- Auditors
- KPMG AZSA LLC
Upcoming Events for 3540
Similar to 3540
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
As of Today at 19:05 UTC, shares in CI Medical Co are trading at ¥3,920. This share price information is delayed by 15 minutes.
Shares in CI Medical Co last closed at ¥3,920 and the price had moved by -20.49% over the past 365 days. In terms of relative price strength the CI Medical Co share price has underperformed the Nikkei 225 Index by -40.16% over the past year.
The overall consensus recommendation for CI Medical Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The CI Medical Co dividend yield is 0.64% based on the trailing twelve month period.
Last year, CI Medical Co paid a total dividend of ¥25, and it currently has a trailing dividend yield of 0.64%. We do not have any data on when CI Medical Co is to next pay dividends.
We do not have data on when CI Medical Co is to next pay dividends. The historic dividend yield on CI Medical Co shares is currently 0.64%.
To buy shares in CI Medical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥3,920, shares in CI Medical Co had a market capitalisation of ¥39bn.
Here are the trading details for CI Medical Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 3540
Based on an overall assessment of its quality, value and momentum CI Medical Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in CI Medical Co is ¥4,800. That is 22.45% above the last closing price of ¥3,920.
Analysts covering CI Medical Co currently have a consensus Earnings Per Share (EPS) forecast of ¥243 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CI Medical Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -16.46%.
As of the last closing price of ¥3,920, shares in CI Medical Co were trading -3.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CI Medical Co PE ratio based on its reported earnings over the past 12 months is 15.15. The shares last closed at ¥3,920.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
CI Medical Co's management team is headed by:
- Kiyoto Shimizu - PRE
- Yoshimitsu Kobayashi - SMD
- Hideaki Yutani - SMD
- Masaharu Yamauchi - MDR
- Takahiro Yamaguchi - DSL
- Keiichiro Hayashi - EXO
- Naonori Kawabata - EXO
- Tomoko Shimizu - EXO
- Seiji Miyoshi - OTH
- Yasuyuki Nakanishi - OTH
- Akira Okusawa - IND